http://publicationslist.org/data/antonio.sanzo/atom.xml Antonio Sanzohttp://publicationslist.org/antonio.sanzo$basepathfavicon.icoRecent additions to Antonio Sanzo's PublicationsList.org pagehttp://publicationslist.org/publications.png2011-01-22T12:30:35Z http://publicationslist.org/antonio.sanzo/refid11 2011-01-22T12:08:01Z

Background: An increased risk of delayed cardiac perforation (DCP) with active-fixation small-diameter ICD leads has recently been reported, especially with regard to the St. Jude Riata lead (St. Jude Medical, Sylmar, CA, USA). Few data on the risk of DCP in small versus standard-diameter leads implanted in a single high-volume center are available. Moreover, no data on the performances of St. Jud...<br/><br/>Roberto Rordorf, Fabio Canevese, Alessandro Vicentini, Barbara Petracci, Simone Savastano, Antonio Sanzo, Edoardo Gandolfi, Roberto Dore, Maurizio Landolina (2011) <i>Pacing Clin Electrophysiol</i> <i></i> <i></i> : <br/>

http://publicationslist.org/antonio.sanzo/refid5 2010-11-01T21:23:51Z

Aims In chronic heart failure (CHF), reduced vagal activity correlates with increased mortality and acute decompensation. Experimentally, chronic vagus nerve stimulation (VNS) improved left ventricular (LV) function and survival; clinically, it is used for the treatment of drug-refractory epilepsy. We assessed safety and tolerability of chronic VNS in symptomatic CHF patients, using a novel implan...<br/><br/>Gaetano M De Ferrari, Harry J G M Crijns, Martin Borggrefe, Goran Milasinovic, Jan Smid, Markus Zabel, Antonello Gavazzi, Antonio Sanzo, Robert Dennert, Juergen Kuschyk, Srdjan Raspopovic, Helmut Klein, Karl Swedberg, Peter J Schwartz (2010) <i>Eur Heart J</i> <i></i> <i></i> : <br/>

http://publicationslist.org/antonio.sanzo/refid10 2010-11-01T21:25:40Z

AIMS: The purpose of this study was to evaluate adherence to national guidelines on the non-pharmacologic (ablative) treatment of atrial fibrillation (AF). METHODS AND RESULTS: This prospective, observational, transversal study enrolled 1256 consecutive in- and outpatients referred to 43 cardiology departments between 1 and 31 October 2008 for the management of AF as a primary diagnosis. A rhythm-...<br/><br/>Nicola Bottoni, Massimo Tritto, Renato Ricci, Michele Accogli, Matteo Di Biase, Saverio Iacopino, Matteo Iori, Sakis Themistoclakis, Nadir Sitta, Gianmario Spadacini, Roberto De Ponti, Michele Brignole (2010) <i>Europace</i> <i></i> <i></i> 12: 8 1070-1077<br/>

http://publicationslist.org/antonio.sanzo/refid4 2010-11-01T21:23:51Z

BACKGROUND: Prophylactic implantable cardioverter-defibrillator (ICD) therapy reduces mortality in patients with heart failure (HF) and reduced left ventricular ejection fraction (LVEF), but the absolute risk reduction is relatively small. Thus, there is a strong need to identify reliable risk stratifiers, particularly among patients with nonischemic cardiomyopathy (NIDCM), in whom the search for ...<br/><br/>Gaetano M De Ferrari, Antonio Sanzo (2009) <i>Heart Rhythm</i> <i></i> <i></i> 6: 3 Suppl S29-S35<br/>

http://publicationslist.org/antonio.sanzo/refid6 2010-11-01T21:23:51Z

Increased sympathetic and reduced vagal activity predict increased mortality in patients with congestive heart failure (CHF). Experimentally, vagal stimulation (VS) is protective both during acute myocardial ischemia and in chronic heart failure. In man, VS is used in refractory epilepsy but has never been used in cardiovascular diseases. Thus, there is a strong rationale to investigate the effect...<br/><br/>Gaetano M De Ferrari, Antonio Sanzo, Peter J Schwartz (2009) <i>Conf Proc IEEE Eng Med Biol Soc</i> <i></i> <i></i> 2009: 2037-2039<br/>

http://publicationslist.org/antonio.sanzo/refid3 2010-11-01T21:23:51Z

BACKGROUND: Experimentally, vagal stimulation (VS) is protective in chronic heart failure (HF). In man, VS is used in refractory epilepsy but has never been used in cardiovascular diseases. Increased sympathetic and reduced vagal activity predict increased mortality in HF. AIMS: This pilot study assessed feasibility and safety and tested possible efficacy of chronic VS in HF patients. METHODS: We ...<br/><br/>Peter J Schwartz, Gaetano M De Ferrari, Antonio Sanzo, Maurizio Landolina, Roberto Rordorf, Claudia Raineri, Carlo Campana, Miriam Revera, Nina Ajmone-Marsan, Luigi Tavazzi, Attilio Odero (2008) <i>Eur J Heart Fail</i> <i></i> <i></i> 10: 9 884-891<br/>

http://publicationslist.org/antonio.sanzo/refid7 2011-01-22T12:09:15Z

Lia Crotti, M Pedrazzini, R Insolia, C Ferrandi, A Ghidoni, A Sanzo, F Dagradi, G M De Ferrari, P J Swartz (2008) <i>Hum Genet</i> <i></i> <i></i> 123: 5 <br/>

http://publicationslist.org/antonio.sanzo/refid9 2011-01-22T12:09:15Z

Lia Crotti, R Insolia, C Ferrandi, M Pedrazzini, A Cuoretti, E Gandolfi, A Sanzo, F Dagradi, P J Schwartz (2008) <i>Hum Genet</i> <i></i> <i></i> 123: 5 <br/>

http://publicationslist.org/antonio.sanzo/refid8 2011-01-22T12:09:15Z

Lia Crotti, C Ferrandi, M Pedrazzini, R Insolia, A Cuoretti, A Sanzo, F Dagradi, G M De Ferrari, P J Schwartz (2008) <i>Hum Genet</i> <i></i> <i></i> 123: 5 <br/>

http://publicationslist.org/antonio.sanzo/refid1 2010-11-01T21:23:51Z

OBJECTIVES: This study sought to assess the long-term predictive power of depressed baroreflex sensitivity (BRS) among post-myocardial infarction (MI) patients with preserved left ventricular function. BACKGROUND: Risk stratification after MI is primarily performed by identifying patients with depressed left ventricular ejection fraction (LVEF) because of their greater mortality. Autonomic markers...<br/><br/>Gaetano M De Ferrari, Antonio Sanzo, Alessandra Bertoletti, Giuseppe Specchia, Emilio Vanoli, Peter J Schwartz (2007) <i>J Am Coll Cardiol</i> <i></i> <i></i> 50: 24 2285-2290<br/>

http://publicationslist.org/antonio.sanzo/refid2 2008-08-23T18:31:05Z

Oral estrogen treatment increases thrombotic risk. Tissue factor (TF), tissue factor pathway inhibitor (TFPI), and platelet interaction with leukocytes are important determinants of thrombogenesis. Therefore, the present study was designed to define and compare platelet TF and TFPI mRNA and adhesion protein expression in platelets derived from animals treated with different types of oral estrogens...<br/><br/>Muthuvel Jayachandran, Antonio Sanzo, Whyte G Owen, Virginia M Miller (2005) <i>Am J Physiol Heart Circ Physiol</i> <i></i> <i></i> 289: 5 H1908-H1916<br/>